Combined phacoemulsification and viscocanalostomy with Ologen implant versus combined phacoemulsification and viscocanalostomy

Table 1 Demographic and preoperative data, and follow-up period of the studied groups

Parameters	Phaco-viscocanalostomy group (n = 39)	Phaco-viscocanalostomy with Ologen® implant group (n = 40)	p value
Age; yrs
Range	40–81	41–79
Mean ± SD	57.95 ± 9.61	58.18 ± 9.00	0.91^†
Sex; n (%)
Male	16 (41.0)	17 (42.5)
Female	23 (59.0)	23 (57.5)	0.89^‡
Visual acuity
Range	0.1–0.7	0.1–0.6
mean ± SD	0.41 ± 0.18	0.37 ± 0.17	0.33^†
IOP^a; mmHg
Range	15–25	15–26
mean ± SD	19.46 ± 3.26	19.18 ± 3.19	0.69^†
Antiglaucoma drugs; n
Range	2–4	2–4
mean ± SD	2.85 ± 0.87	2.88 ± 0.91	0.70^§

ISSN: 1471-2415